天冬氨酸转氨酶/丙氨酸转氨酶比值(De Ritis比值)可预测大面积烧伤患者生存
单中心回顾性队列研究纳入2005年至2018年长海医院烧伤科351例大面积烧伤患者,分析年龄、性别、总体表面积、De Ritis比值及血清白蛋白对死亡率的影响。结果显示年龄、TBSA、吸入性损伤和De Ritis比值是30天及90天死亡率的独立危险因素,且De Ritis比值对严重烧伤患者死亡率的预测优于血清白蛋白。
要点
- De Ritis比值是大面积烧伤患者30天和90天死亡率的独立危险因素。
- De Ritis比值预测30天和90天死亡率的AUC分别为0.771和0.750。
- De Ritis比值对严重烧伤患者预后评估优于血清白蛋白。
核心结论
- De Ritis比值可作为大面积烧伤患者预后的有效指标,通过血液检查即可方便获取。
- 无论预测30天还是90天死亡率,De Ritis比值均保持较高准确性,且优于血清白蛋白。
研究设计与样本
- 单中心回顾性观察性队列研究,纳入长海医院烧伤科2005年5月1日至2018年4月30日收治的351例大面积烧伤患者。
- 采用单因素和多因素logistic回归分析年龄、性别、TBSA、De Ritis比值和血清白蛋白等变量对死亡率的影响。
- 通过ROC曲线分析评估诊断价值并确定截断值,采用Kaplan-Meier曲线展示De Ritis比值和血清白蛋白对生存的影响。
主要发现
- 队列以男性为主(74.64%),78.35%的患者为火焰烧伤。
- 年龄、TBSA、吸入性损伤和De Ritis比值是30天死亡率的独立危险因素。
- 年龄、TBSA、吸入性损伤和De Ritis比值是90天死亡率的独立危险因素。
- De Ritis比值预测30天死亡率的AUC为0.771(95%CI 0.708-0.835),预测90天死亡率的AUC为0.750(95%CI 0.683-0.818)。
- De Ritis比值在严重烧伤患者中预测死亡率优于血清白蛋白。
临床怎么用
- 对大面积烧伤患者,可通过常规血液检查计算De Ritis比值,辅助评估30天和90天死亡风险。
- 在预后评估中,De Ritis比值可作为优于血清白蛋白的参考指标。
局限性
- 单中心回顾性研究,结果需多中心前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although treatment of burn patients has significantly improved in recent decades, major burns remain fatal. Therefore, the evaluation of the death risk of the patients with extensive burns is very important. The ratio between the serum levels of aspartate transaminase and alanine transaminase (De Ritis ratio) was an independent predictor of poor outcomes in patients with acute ischemic stroke, cardiac surgery, non-metastatic renal cell carcinoma, and upper urinary tract urothelial carcinoma. Our aim was to determine whether the ratio between the serum levels of AST and ALT (De Ritis ratio) was useful to assess prognosis in extensively burned patients. METHODS: We conducted a single-center cohort study at the Burns Department of Changhai Hospital. This retrospective observational analysis was performed based on the clinical data of major burn patients admitted between May 1, 2005 and April 30, 2018. Univariate and multivariate logistic regression analyses were performed on variables such as age, sex, total body surface area (TBSA), De Ritis ratio, and serum albumin level, which may affect mortality in major burn patients. We assessed their diagnostic value and found the cut-off value by receiver operative characteristic (ROC) curve analysis. We used the Kaplan-Meier curve to display the impact of the De Ritis ratio and serum albumin level on survival in burn patients. RESULTS: A total of 351 patients with extensive burns were included in the study. The cohort predominantly consisted of males (74.64%), and most of the patients (78.35%) had been burned by a flame. Age, TBSA, inhalation, and the De Ritis ratio were found to be independent risk factors for the 30-days mortality of major burn patients, while age, TBSA, inhalation, and the De Ritis ratio were independent risk factors for 90-day mortality. Further, the De Ritis ratio was a better mortality predictor than serum albumin in severely burned patients, whose area under ROC for 30-day and 90-day mortality was 0.771 (95% confidence intervals [CI], 0.708-0.835) and 0.750 (95% CI, 0.683, 0.818). CONCLUSIONS: The De Ritis ratio was useful as a prognostic indicator for major burn patients, which can be conveniently obtained through blood examination. Regardless of whether the prediction was for 30-day or 90-day mortality, the accuracy remained high. Moreover, compared to serum albumin level, the De Ritis ratio was superior in assessing the prognosis of extensively burned patients.
引用
- Wang B, Hu L, Chen Y, et al. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients. Burns. 2021. PMID: 34456097. doi:10.1016/j.burns.2021.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。